Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma.
Genome Med. 2022 May 30;14(1):58. doi: 10.1186/s13073-022-01060-8.
Genome Med. 2022.
PMID: 35637530
Free PMC article.